Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease.
about
Coronary CT angiography: Beyond morphological stenosis analysis.Comparison of treadmill exercise stress cardiac MRI to stress echocardiography in healthy volunteers for adequacy of left ventricular endocardial wall visualization: A pilot study.2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology.MRI and CT in the diagnosis of coronary artery disease: indications and applications.Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery diseaseMyocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography.Quantitative assessment of magnetic resonance derived myocardial perfusion measurements using advanced techniques: microsphere validation in an explanted pig heart system.Evaluation of a comprehensive cardiovascular magnetic resonance protocol in young adults late after the arterial switch operation for d-transposition of the great arteriesDiagnostic performance of dual-energy CT stress myocardial perfusion imaging: direct comparison with cardiovascular MRIHyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.Performance of adenosine "stress-only" perfusion MRI in patients without a history of myocardial infarction: a clinical outcome studyComparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.CT fractional flow reserve: the next level in non-invasive cardiac imagingThe effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study.Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findings.Myocardial perfusion is impaired in asymptomatic renal and liver transplant recipients: a cardiovascular magnetic resonance studyDesign and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease.Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease.Identification of left ventricular myocardial ischemia and cardiac prognosis with cardiovascular magnetic resonance: updates from 2008 to 2010.Cardiac MRI for myocardial ischemiaConcordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA.Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-teImaging oxygen metabolism with hyperpolarized magnetic resonance: a novel approach for the examination of cardiac and renal functionAnatomy and physiology of coronary blood flow.Imaging as an End Point in Ischemia Trials.The role of cardiac magnetic resonance imaging following acute myocardial infarction.Cardiovascular magnetic resonance imaging in ischemic heart disease.Coronary pressure-derived fractional flow reserve in the assessment of coronary artery stenoses.Myocardial perfusion distribution and coronary arterial pressure and flow signals: clinical relevance in relation to multiscale modeling, a review.Advances in cardiac magnetic resonance imaging of congenital heart disease.Multi-modality imaging for the assessment of myocardial perfusion with emphasis on stress perfusion CT and MR imaging.Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.Response to letter regarding article, "stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease".Ultrasonic Transducer-Guided Electrochemical Impedance Spectroscopy to Assess Lipid-Laden Plaques.Fractional flow reserve as the reference standard for myocardial perfusion studies: fool's gold?Magnetic resonance myocardial perfusion imaging at 3.0 Tesla for the identification of myocardial ischaemia: comparison with coronary catheter angiography and fractional flow reserve measurements.Simple motion correction strategy reduces respiratory-induced motion artifacts for k-t accelerated and compressed-sensing cardiovascular magnetic resonance perfusion imaging.Assessment of myocardial ischemia by strain dobutamine stress echocardiography and cardiac magnetic resonance perfusion imaging before and after coronary artery bypass grafting.Combined Assessment of Stress Myocardial Perfusion Cardiovascular Magnetic Resonance and Flow Measurement in the Coronary Sinus Improves Prediction of Functionally Significant Coronary Stenosis Determined by Fractional Flow Reserve in Multivessel DiDiagnostic performance of static single-scan stress perfusion cardiac computed tomography in detecting hemodynamically significant coronary artery stenosis: a comparison with combined invasive coronary angiography and cardiovascular magnetic resonan
P2860
Q27691369-AD0B7BC9-D598-4D1D-847D-4860D5D248E5Q30413148-415F340D-70A7-4BB8-947D-4EA65E1EDBE6Q30423759-78E78185-FBD7-48D7-AD15-D75DDE9833C9Q30470368-13AAB3A0-48E2-45F7-A004-5D9FBFAB1D17Q33588782-8404FD0B-A2D0-4796-A74E-D0A96D7D5AB5Q33741484-17F96F3B-06D5-4927-916D-0C20A9F9BDF1Q34333363-1E0E696A-69DF-4E4A-9BEE-F2871A01B148Q34678144-DBCE7C57-46C0-4F5C-95F2-62A1BF89C66AQ34720521-1ADD6AD7-10BF-4191-9238-88B6C69E46BCQ35298233-52EE930A-B3C4-47AF-B733-98DEEEC15DD4Q35745588-C671D5CC-C765-4270-96DA-8F9E3B3C5B9AQ36212249-7618B31E-A504-4D0B-8A89-A4CB6CC448F3Q36227317-E514B2E3-8029-4B6C-8AF5-36FB5009EFE9Q36296064-AF2704B1-7C52-46A7-B046-1CCF138F782EQ36325926-793B996A-075F-4517-A4A4-CD4254A5516DQ36433342-8F1C0036-5A1B-476F-91FE-552508A4287CQ36498991-8F7CCD50-2773-4BD3-8FEE-601B1F9EDC9EQ37105989-02A1E25A-CDA4-421F-AB81-01EAA9EBC132Q37156108-0E4DC228-5B77-4C48-9047-FE8AFE6B649CQ37195686-86A24B94-5C23-431E-80D5-C29F89A249AAQ37526226-631218BD-6BC4-4E95-A201-0AC6CCA10F66Q37572029-A9B37F87-C74C-4910-919D-BFC24BC90FE1Q37609813-4B342027-2F31-4F4F-9923-FCB9A86454D9Q37762484-7B24DC43-8DCE-4438-BE38-67C6D1E76D87Q37863002-B40EED76-2D4D-4794-A901-C2E704718E82Q37996927-281814FE-8B58-4257-A467-A26D45A7812DQ38018564-67F3F650-5150-4984-A42B-66EE82E6B6ECQ38062374-FC134A65-4C0D-42C9-AF5F-A59894C14105Q38124722-4FCFB147-F130-4C14-8D45-9A7A0945F34CQ38304851-70F832B9-B4FA-4ACB-A59E-07E2121AC86CQ38391213-9F1F559F-15EA-4C77-B9C8-4C7C06B9B136Q38589870-E1FD9ACC-098B-4482-A82D-9FFC438E85DDQ42650944-3C38D870-5C1E-4BDB-9633-2E6275257EA8Q42669148-EC2B1FEC-86A3-4786-996C-DF59905248CEQ45393918-4075C1D7-BC8C-4BD8-AFC8-26D0E077F683Q45931151-D2D9F170-0AA1-4C22-865F-50BF43A3ADBAQ47642307-CA81A527-3B6F-46E0-892A-4C708A42DA48Q48273618-BDDCD9A5-7159-4E6C-8F82-9EAA53CB6FC3Q50063990-EDF8419C-297A-48D9-B2DE-90B209ABB566Q50102833-15B3AD16-EA92-4298-B9CD-162D9EA37BC5
P2860
Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Validation of magnetic resonan ...... ficant coronary heart disease.
@en
Validation of magnetic resonan ...... ficant coronary heart disease.
@nl
type
label
Validation of magnetic resonan ...... ficant coronary heart disease.
@en
Validation of magnetic resonan ...... ficant coronary heart disease.
@nl
prefLabel
Validation of magnetic resonan ...... ficant coronary heart disease.
@en
Validation of magnetic resonan ...... ficant coronary heart disease.
@nl
P2093
P1433
P1476
Validation of magnetic resonan ...... ficant coronary heart disease.
@en
P2093
Henry J Dargie
Jonathan Lyne
Keith G Oldroyd
Mairi-Jean McLaughlin
Richard Good
Ross McGeoch
Stuart Watkins
Tony Cunningham
Tracey Steedman
P304
P356
10.1161/CIRCULATIONAHA.109.872358
P407
P577
2009-11-16T00:00:00Z